Lumigan (Bimatoprost) - Drug Interactions, Contraindications, Overdosage, etc

DRUG INTERACTIONS

LUMIGAN drug label information in our database does not contain a dedicated section on drug interactions. Please check subsections of WARNINGS AND PRECAUTIONS as well as other sources.

OVERDOSAGE

No information is available on overdosage in humans. If overdose with LUMIGAN ^® (bimatoprost ophthalmic solution) 0.03% occurs, treatment should be symptomatic.

In oral (by gavage) mouse and rat studies, doses up to 100 mg/kg/day did not produce any toxicity. This dose expressed as mg/m² is at least 70 times higher than the accidental dose of one bottle of LUMIGAN ^® for a 10 kg child.

CONTRAINDICATIONS

LUMIGAN ^® (bimatoprost ophthalmic solution) 0.03% is contraindicated in patients with hypersensitivity to bimatoprost or any other ingredient in this product.